Loading clinical trials...
Loading clinical trials...
Cytoreductive surgery (CRS), with or without hyperthermic intraperitoneal chemotherapy (HIPEC), is currently the standard treatment for advanced peritoneal tumors, including pseudomyxoma peritonei (PM...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Jules Bordet Institute
NCT05597683 · Cytoreductive Surgery, Hyperthermic Intra-peritoneal Chemotherapy, and more
NCT05942209 · Gynecologic Cancer, Anastomotic Leak, and more
NCT05353582 · Colorectal Neoplasms, Colorectal Cancer, and more
NCT05063019 · Hyperthermic Intraperitoneal Chemotherapy, Cytoreductive Surgery, and more
NCT01962480 · Ventral Hernias
Jules Bordet Institute
Anderlecht, Brussels Capital
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions